RecruitingNot Applicable

HIV Treatment Adherence Dose Determination Trial

United States400 participantsStarted 2020-09-01

Plain-language summary

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed HIV positive * Confirmed prescribed antiretroviral therapy * Confirmed non-adherent to anti-retroviral therapy Exclusion Criteria: * Does not have access to a phone * Does not have access to the internet

What they're measuring

Change in Antiretroviral Therapy Adherence from Baseline to 12-Months

Timeframe: 12-Month

Change in HIV Viral Load from Baseline to 12-months

Timeframe: 12-months

Trial details

NCT IDNCT04577313

SponsorUniversity of Connecticut

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11-30

Contact for this trial

Seth Kalichman, PhD

860 208 3706 seth.k@uconn.edu

View on ClinicalTrials.gov More HIV Infections trials